Document is current

Article History

Received: 6 February 2024

Accepted: 19 March 2024

First Online: 5 June 2024

Declarations

:

: The study was approved by the Cantabria Clinical Research Ethics Committee (approval number 2021.414), and was conducted in accordance with the Declaration of Helsinki and the International Conference for Harmonization. All data extracted from the medical records were stored de-identified prior to the analysis. As per the Clinical Research Ethics Committee, this retrospective research did not require informed consent.

: Not applicable.

: Disclosures that might be interpreted as constituting possible conflict(s) of interest for the study: Javier Loricera had consultation fees/participation in company-sponsored speaker´s bureau from Roche, AbbVie, Galápagos, Novartis, UCB Pharma, MSD, Celgene, Astra Zeneca, and Grünenthal and received support for attending meetings and/or travel from Janssen, AbbVie, Roche, Novartis, MSD, UCB Pharma, Celgene, Lilly, Pfizer, and Galápagos. Diana Prieto-Peña has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from UCB Pharma, Novartis, Amgen, Lilly, Sanofi, and Janssen, and received support for attending meetings and/or travel from Lilly, Roche, Sanofi, Pfizer and Abbvie. Susana Romero-Yuste has received grants/recents supports from Abbvie, Lilly, Pfizer, and Galápagos. Eugenio de Miguel Research funding/consulting and conferences fees from: Abbvie, Novartis, Pfizer, Roche, Janssen, Lilly, MSD, BMS, UCB, Grünenthal, and Sanofi, and received support for attending meetings and/or travel from Abbvie, Pfizer, Sanofi, and Grünenthal. Iván Ferraz-Amaro would like to acknowledge that he has received grants/research supports from Abbvie, MSD, Janssen, and Roche, as well as consultation fees from company sponsored speakers bureaus associated with Abbvie, Pfizer, Roche, Sanofi, Celgene, and MSD, and received support for attending meetings and/or travel from Abbvie, MSD, Janssen, Pfizer, Roche, Sanofi, and Celgene. Eva Galíndez-Agirregoikoa had consultation fees/participation in company-sponsored speaker´s bureau from Lilly, Janssen, Abbvie, and Amgen, and received support for attenting meetings and/or travel from Lilly, Abbvie, and Pfizer. Ismael González-Fernández had consultation fees/participation in company-sponsored speaker´s bureau from Novartis, Janssen, Grunenthal, MSD, and Theramex, and received support for attending meetings and/or travel from Janssen, and MSD. Ana Urruticoechea-Arana had received research grants, fees for consultancies or presentations and participated in medical meetings or courses from Abbvie, Galápagos, UCB, Pfizer, MSD, Novartis, GSK, Hanssen, and Amgen, and participated on a data safety monitoring board or advisory board GSK. Ángel Ramos-Calvo had consultation fees/participation in company-sponsored speaker´s bureau from Amgen, UCB, and Galápagos, and received support for attending meetings and/or travel from Pfizer. Fernando López-Gutiérrez received support for attending meetings and/or travel from Janssen, Abbvie, Roche, Novartis, MSD, UCB Pharma, Celgene, Lilly, Pfizer, and Galápagos. Santos Castañeda has received research supports from MSD, and Pfizer and had consultation fees/participation in company-sponsored speaker’s bureau from BMS, Eli-Lilly, MSD, Roche, and UCB, and received support for attending meetings and/or travel from BMS, Lilly, MSD, Roche, and UCB. Sebastian Unizony received research support from Genentech, participated in an advisory board for Abbvie, and provided consulting for Sanofi, Kiniksa, and Janssen.Ricardo Blanco received grants/research support from AbbVie, MSD, and Roche, and had consultation fees/participation in a company-sponsored speaker’s bureau from AbbVie, Pfizer, Roche, GSK, Lilly, UCB, Bristol-Myers, Novartis, Janssen, UCB and MSD, and received support for attending meetings and/or travel from AbbVie, Pfizer, Roche, GSK, Lilly, UCB, Bristol-Myers, Novartis, Janssen, UCB, and MSD. <i>The following authors did not declare financial disclosure</i>: Toluwalase Tofade, Anne Riveros-Frutos, Eztizen Labrador, Olga Maiz, Elena Becerra, Javier Narváez. The following authors did not declare financial disclosure: Toluwalase Tofade, Anne Riveros-Frutos, Eztizen Labrador, Olga Maiz, Elena Becerra, Javier Narváez.